July 2020
Pathology play LBT Innovations launches raising
ASX-listed biotech LBT Innovations has inked an agreement with an American medical testing company - and now wants fresh funds to help make the most of it.
- Sarah Thompson, Anthony Macdonald and Tim Boyd
June 2019
Biotech LBT Innovations taps Hawkesbury Partners for raising
Shares in ASX-listed LBT Innovations are in a trading halt while the company raises fresh funds to accelerate its sales and marketing efforts.
- Sarah Thompson and Anthony Macdonald
October 2016
LBT soars after US FDA approves its plate assessment system
Automated technology able to 'read' microbiology culture plates in a lab faster than a human has put a rocket under LBT's share price.
- Updated
- Simon Evans
August 2011
LBT Innovations
The Adelaide-based group, which makes automated testing products for pathology labs, reported a drop in profit because it did not receive a $3.4 million “milestone” payment that was issued in 2010.
- Updated
September 2010
China a lucrative market for Industrea
Mining equipment firm Industrea enjoyed its best one-day jump in three months after it moved to mop up all outstanding convertible bonds.
- Updated
- Brendon Lau
July 2010
Minor pharmas could become next prey
The $2.7 billion bid for hospital operator Healthscope has turned the corporate action spotlight on the health care sector, particularly the smaller end of the market.
- Updated
- Brendon Lau
August 2006
Halting start for roads spin-off
Sydney Roads Group, the toll-road owner, struggled in its debut on the Australian Stock Exchange yesterday in a mixed day for the three market newcomers in which two closed in the red.
- Henry Byrne